Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Varicose veins

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    28 result(s) found for: Varicose veins. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2010-021615-17 Sponsor Protocol Number: 26141788A Start Date*: 2010-08-31
    Sponsor Name:Lars H. Rasmussen
    Full Title: Randomized trial comparing endovascular laser, foam sclerotherapy and stripping in patients with varicose veins due to incompetent small saphenous vein
    Medical condition: Varicose veins
    Disease: Version SOC Term Classification Code Term Level
    12.1 10047001 Varicose veins LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-004565-33 Sponsor Protocol Number: EASI Start Date*: 2006-11-16
    Sponsor Name:Chemische Fabrik Kreussler & Co.GmbH
    Full Title: Efficacy and safety of Aethoxysklerol compared to Sodium Tetradecyl Sulfate and Isotonic Saline (placebo) for the treatment of reticular veins and spider veins including subgroup to investigate the...
    Medical condition: Patients suffering from varicose veins (spider veins or reticular veins in the legs) should be treated with a sclerosing agent.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10047001 Varicose veins LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2004-005147-10 Sponsor Protocol Number: KORPO - 0104 Start Date*: 2005-01-31
    Sponsor Name:KORPO S.R.L.
    Full Title: Randomised controlled clinical trial to evaluate the efficacy of a sodium salicylate hydroglyceric solution used at different concentrations in the aesthetic and functional sclerotherapy of veins, ...
    Medical condition: Patients with ecstatic vessels in inferior limbs
    Disease: Version SOC Term Classification Code Term Level
    6.1 10057165 HLGT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-001069-26 Sponsor Protocol Number: 06/45/02 Start Date*: 2009-04-06
    Sponsor Name:University of Aberdeen
    Full Title: Randomised controlled trial comparing foam sclerotherapy, alone or in combination with endovenous laser therapy, with conventional surgery as a treatment for varicose veins
    Medical condition: Varicose Veins
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047013 Varicose veins of lower extremities LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2005-005482-10 Sponsor Protocol Number: RN1001-0042 Start Date*: 2006-03-13
    Sponsor Name:Renovo
    Full Title: A double blind, placebo controlled, randomised dose response trial to investigate the efficacy of Juvista in the improvement of scar appearance when applied to approximated wound margins following ...
    Medical condition: Patients undergoing varicose vein removal with ligation and stripping.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) LT (Completed) LV (Completed) BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-005612-91 Sponsor Protocol Number: n.a. Start Date*: 2008-04-30
    Sponsor Name:Sektion Chirurgische Forschung, Univ.Klinik f.Chirurgie
    Full Title: Improving wound healing in chronic ulcus cruris venosum with native fibrin enriched with endogenous thrombocytes (controlled prospective randomized study)
    Medical condition: The study aims to evaluate the postulated improvement in wound healing with additive application of autologous fibrin enriched with autologous thrombocytes in the treatment of chronic crural venous...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10045346 Ulcerated varicose veins LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-016965-26 Sponsor Protocol Number: 108/140 Start Date*: 2010-12-13
    Sponsor Name:Centro Comunitario de Sangre y Tejidos de Asturias
    Full Title: Ensayo clínico multicéntrico, aleatorizado, abierto para valorar la eficacia y seguridad del tratamiento de úlceras venosas crónicas con injertos cutáneos cultivados
    Medical condition: Úlceras venosas crónicas
    Disease: Version SOC Term Classification Code Term Level
    9 10047259 Venous ulcer NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2016-004347-37 Sponsor Protocol Number: VSV2016b Start Date*: 2017-01-31
    Sponsor Name:Helsinki University Hospital
    Full Title: Femoralblock in endovenous laser
    Medical condition: venous disease
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-017050-12 Sponsor Protocol Number: n.a. Start Date*: 2010-02-25
    Sponsor Name:Sektion Chirurgische Forschung
    Full Title: Improving wound healing in chronic ulcus cruris venosum with native fibrin enriched with endogenous platelets and vagal stimulation with p-Stim (a pilot study)
    Medical condition: The study aims to evaluate the improvement in wound healing in chronic crural venous ulcers by comparing additive application of autologous fibrin enriched with autologous thrombocyted to standardi...
    Disease: Version SOC Term Classification Code Term Level
    12.0 10045346 Ulcerated varicose veins LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-003341-10 Sponsor Protocol Number: NL47979.091.14 Start Date*: 2018-01-16
    Sponsor Name:Rijnstate
    Full Title: Registry of the treatment of primay insufficiency of the great saphenous vein with a diameter >/= 12 mm, anterolateral branches, or great saphenous vein insufficiency below the knee with mechano-...
    Medical condition: varicose veins of the infragenual great saphenous vein, large supragenual great saphenous vein (>= 12 mm) and antero-lateral branch varicose veins
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-004831-47 Sponsor Protocol Number: TWO2-001 Start Date*: 2007-11-30
    Sponsor Name:Linde Gas Therapeutics
    Full Title: Topical Wound Oxygen vs. Compression Therapy in the Management of Refractory, Non-Healing Venous Leg Ulcers; A prospective Randomised Controlled Trial
    Medical condition: Chronic, refarctory, non-healing venous ulcers with a duration of more than two years.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047260 Venous ulceration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-002695-34 Sponsor Protocol Number: CS-201 Start Date*: 2009-01-23
    Sponsor Name:Kringle Pharma Europe AB
    Full Title: A Phase I/II Double-Blind, Dose Ranging, Vehicle Controlled, Randomized, Parallel Groups, Safety, Tolerability and Efficacy Study of ChronSeal® (5-amino-acid deleted recombinant human Hepatocyte Gr...
    Medical condition: Non-malignant full skin chronic venous leg ulcers of an area 3 - 20 cm2.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047260 Venous ulceration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2021-001341-12 Sponsor Protocol Number: UV/AP/21 Start Date*: 2023-04-14
    Sponsor Name:Red Andaluza de Diseño y Traslación en Terapias Avanzadas - Fundación Pública Andaluza Progreso y Salud M.P.
    Full Title: Phase I-II, Multicenter, Randomized, Controlled, Proof of Concept Clinical Trial to determine feasibility, safety and efficacy of the use of Allogenic adipose-derived adult mesenchymal stem cells e...
    Medical condition: Venous ulcer
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004858 10047259 Venous ulcer NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-001483-30 Sponsor Protocol Number: BBH-GMCSF-01 Start Date*: 2020-06-18
    Sponsor Name:Reponex Pharmaceuticals A/S
    Full Title: Effect of topical rhGM-CSF on the healing of venous leg ulcers: a randomized, placebo-controlled, double-blind, clinical phase II study
    Medical condition: Venous leg ulcers
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004858 10047260 Venous ulceration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-021270-11 Sponsor Protocol Number: CL2-05682-102 Start Date*: 2010-09-30
    Sponsor Name:Institut de Recherches Internationales Servier
    Full Title: Impact of Daflon 500 mg on the progression of chronic venous disease and symptoms in patients operated on for varicose veins with conservation of the great saphenous vein. A multicentre, double bl...
    Medical condition: Patients suffering from chronic venous disease and for whom ASVAL (Ambulatory Selective Varicose veins Ablation Local anesthesia) surgery is indicated.
    Disease: Version SOC Term Classification Code Term Level
    12.1 10066682 Chronic venous insufficiency LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2014-001001-40 Sponsor Protocol Number: DT-DP-UC-CR-01 Start Date*: 2014-06-13
    Sponsor Name:DermaTools Biotech GmbH
    Full Title: A multicentre, double-blind, randomised, controlled phase II/III study to evaluate the efficacy and safety of the new wound healing solution Diperoxochloric acid (DPOCl, DermaPro®) in patients with...
    Medical condition: Venous leg ulcer (ulcus cruris)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LV (Prematurely Ended) LT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2022-000492-39 Sponsor Protocol Number: XIN-XSTEM-201 Start Date*: 2022-07-05
    Sponsor Name:Xintela AB
    Full Title: A multi-centre, randomised, single-blind Phase I/IIa study to evaluate the safety, tolerability and efficacy of a single topical dose of allogeneic integrin α10β1-selected mesenchymal stem cells (X...
    Medical condition: Difficult-to-heal venous leg ulcers
    Disease: Version SOC Term Classification Code Term Level
    21.1 10040785 - Skin and subcutaneous tissue disorders 10047260 Venous ulceration LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2011-005575-16 Sponsor Protocol Number: BufferedTumescenceV3 Start Date*: 2011-12-21
    Sponsor Name:Hull & East Yorkshire Hospitals NHS Trust
    Full Title: Tumescent Anaesthesia in Endovenous Laser Ablation of Varicose Veins: A Randomised Controlled Trial of a Buffered Tumescent Solution
    Medical condition: Pain of injection of a tumescent anaesthetic solution used during EndoVenous Laser Ablation of Varicose Veins.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-005574-39 Sponsor Protocol Number: Surgery&TumescenceV3 Start Date*: 2011-12-21
    Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust
    Full Title: A Randomised Controlled Trial of Tumescent Anaesthesia in addition to Surgical Ligation and Stripping of the Great Saphenous Vein
    Medical condition: Superficial Venous Insufficiency
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2015-000730-30 Sponsor Protocol Number: R1788 Start Date*: 2015-05-21
    Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust
    Full Title: A randomised clinical trial comparing endovenous laser ablation and mechanochemical ablation (ClariVein®) in the management of superficial venous insufficiency.
    Medical condition: Varicose veins (VVs) or Superficial Venous Insufficiency (SVI) of the legs results from inflammation mediated damage to vein structure, allowing reverse flow. SVI affects 30% of adults and is assoc...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 11 01:12:50 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA